Global medical technology major Medtronic plc has appointed Madan Krishnan as Vice President for Indian sub-continent.
In this role, Krishnan will lead the Medtronic Indian sub-continent business (ISC), which includes India, Sri Lanka, Bangladeshand Nepal, Medtronic plc said in a statement.
Commenting on the development, Medtronic AsiaPacific President Bob White said: “”We see tremendous growth potential in ISC and I have full confidence in Madan’s ability to be an engaged and collaborative industry leader while caring for our employees.”
Krishnan joined Medtronic in 2011. Prior to this appointment, Krishnan was vice president of finance, AsiaPacific (APAC).
Medtronic began its operations in Indiain 1979. Headquartered in Mumbai, the company has offices at Ahmedabad, Bengaluru, Chennai, Cochin, Dhaka, Gurgaon, Hyderabad, Kolkata, New Delhi, Puneand Vadodara.
Source: Business Standard
Novo Holdings has concluded the acquisition of all outstanding shares of commercial-stage biopharmaceutical company Paratek Pharmaceuticals for nearly $462m (€433.67m) to bolster its antimicrobial resistance (AMR) expertise. Paratek develops and commercialises new treatments for life-threatening ailments. Its speciality pharmaceutical platform aids in developing new therapeutics.
Glenmark Pharmaceuticals has signed a definitive agreement for the divestiture of a 75% stake in its division, Glenmark Life Sciences (GLS), to Indian company Nirma in a deal valued at Rs56.51bn ($679.85m). Glenmark Life Sciences focuses on producing active pharmaceutical ingredients (API).
Pierre-Alain Ruffieux, CEO of Lonza, will leave the Basel-based company at the end of September. According to the Swiss Contract Development and Manufacturing Organization (CDMO), the separation is by mutual agreement.
